Efficacy of lisdexamfetamine dimesylate in children with attention-deficit/hyperactivity disorder previously treated with methylphenidate: a post hoc analysis
about
Long-acting stimulants for treatment of attention-deficit/hyperactivity disorder: a focus on extended-release formulations and the prodrug lisdexamfetamine dimesylate to address continuing clinical challengesPremarket safety and efficacy studies for ADHD medications in childrenLisdexamfetamine dimesylate: a new therapeutic option for attention-deficit hyperactivity disorder.Post hoc analyses of the impact of previous medication on the efficacy of lisdexamfetamine dimesylate in the treatment of attention-deficit/hyperactivity disorder in a randomized, controlled trialTreatment response and remission in a double-blind, randomized, head-to-head study of lisdexamfetamine dimesylate and atomoxetine in children and adolescents with attention-deficit hyperactivity disorder.Efficacy of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder previously treated with amphetamines: analyses from a randomized, double-blind, multicenter, placebo-controlled titration study.Treatment patterns, resource use, and economic outcomes associated with atypical antipsychotic prescriptions in children and adolescents with attention-deficit hyperactivity disorder in quebec.Efficacy and safety of lisdexamfetamine dimesylate in children with attention-deficit/hyperactivity disorder and recent methylphenidate use.Efficacy and safety of lisdexamfetamine dimesylate and atomoxetine in the treatment of attention-deficit/hyperactivity disorder: a head-to-head, randomized, double-blind, phase IIIb study.Lisdexamfetamine in the treatment of adolescents and children with attention-deficit/hyperactivity disorder.The use of lisdexamfetamine dimesylate for the treatment of ADHD and other psychiatric disorders.Diagnosis and Treatment of Attention Deficit Hyperactivity Disorder During Adolescence in the Primary Care Setting: A Concise ReviewGuanfacine extended release for children and adolescents with attention-deficit/hyperactivity disorder: efficacy following prior methylphenidate treatment.
P2860
Q26822392-C4BBE10E-0D51-4326-BCFE-57289C3F8CD4Q28540563-5C634DFC-ED5A-46E9-B759-FCCD8315CF86Q34032634-8CE45567-980A-4429-872B-BE80F9F7F8F5Q34449469-49138DCC-E7A6-457A-8D1D-5A86D9BA8004Q34459431-A7BAE553-3413-4B53-AFB0-EEB89310F50DQ34518522-55173FE5-95EF-4E02-B256-6CCF9A351AD6Q34575069-4182185C-836C-4248-A4D5-E67A66380524Q36923591-BFFA1827-472D-4535-93C5-5DFC98F184DFQ37330660-78C6DD83-27AA-42F7-8752-F6CCC176BF78Q37561623-07A65F6C-2B47-460E-88F2-FAE566F7FB65Q38221823-3F7307EB-6A30-4EDA-8F49-80B2F78DB711Q38840904-F5E80282-D9DB-4AD2-B420-2B0A4FFBD66DQ39735203-CA13E7E2-8E13-4DDE-8647-3EEF45DE44E5
P2860
Efficacy of lisdexamfetamine dimesylate in children with attention-deficit/hyperactivity disorder previously treated with methylphenidate: a post hoc analysis
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Efficacy of lisdexamfetamine d ...... phenidate: a post hoc analysis
@ast
Efficacy of lisdexamfetamine d ...... phenidate: a post hoc analysis
@en
type
label
Efficacy of lisdexamfetamine d ...... phenidate: a post hoc analysis
@ast
Efficacy of lisdexamfetamine d ...... phenidate: a post hoc analysis
@en
prefLabel
Efficacy of lisdexamfetamine d ...... phenidate: a post hoc analysis
@ast
Efficacy of lisdexamfetamine d ...... phenidate: a post hoc analysis
@en
P2093
P2860
P356
P1476
Efficacy of lisdexamfetamine d ...... phenidate: a post hoc analysis
@en
P2093
Brian Scheckner
Bryan Dirks
Rakesh Jain
Robert Lasser
Teodor Burtea
Thomas Babcock
P2860
P2888
P356
10.1186/1753-2000-5-35
P577
2011-11-04T00:00:00Z
P5875
P6179
1010784062